Business
PAVmed Digital Health Subsidiary, Veris Health, Joins Cancer Moonshot's CancerX Partnership as Founding Member
NEW YORK, June 2, 2023 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed"), a diversified commercial-stage medical technology company, operating in
About this update from Pavmed Inc.
[{"type":"text","content":"NEW YORK, June 2, 2023 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (\"PAVmed\"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, and its majority-owned digital health subsidiary Veris Health Inc. (\"Veris\"), today announced its participation as a founding member of CancerX – a public-private partnership co-hosted by Moffitt Cancer Center and the Digital Medicine Society (\"DiMe\"), alongside the Office for the National Coordinator for Health Information Technology (\"ONC\") and Office of the Assistant Secretary for Health (\"OASH\"). President Biden and Dr. Jill Biden announced CancerX in February 2023 as part of The White House's national Cancer Moonshot initiative to serve as a national accelerator to boost innovation in the fight against cancer.\n\n \n \n \n \n \n \n\n \n\"We are truly honored to be a founding member of CancerX and eager to contribute to this important partnership,\" said James Mitchell, MD, Veris' Chief Medical Officer, and board-certified radiation oncologist. \"At Veris, we firmly believe that digital innovations, such as our Veris Cancer Care Platform, can revolutionize the fight against cancer and lower the burden and disparities for patients undergoing cancer care. Together, we have an unprecedented opportunity to advance best practices in digital health that can positively influence every step of a cancer patient's journey. We look forward to collaborating with other CancerX members to help realize the Cancer Moonshot's ambitious goals.\"\nVeris and other founding members are tasked with driving the success of CancerX by establishing priorities and practices that will harness the full power of innovation to achieve the goals of the Cancer Moonshot initiative. The partnership unites the diverse stakeholders and innovators necessary to leverage the power of digital innovation to realize a cancer-free future.\n\"Multi-stakeholder collaboration is critical to harness the potential of digital innovation in the fight against cancer, and we're honored to partner with Veris Health to achieve the ambitious goals of CancerX,\" said Smit Patel, Associate Program Director at DiMe. \"Through this impressive collaboration, we will establish best practices, build capacity, and demonstrate the impact of innovation on the life o...